Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy
In recent years, hyaluronic acid (HA) has attracted increasing attention as a promising biomaterial for the development of drug delivery systems. Due to its unique properties, such as high biocompatibility, low toxicity, and modifiability, HA is becoming a basis for the creation of targeted drug del...
Saved in:
Main Authors: | Ekaterina Pashkina, Maria Bykova, Maria Berishvili, Yaroslav Lazarev, Vladimir Kozlov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/14/2/61 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alone or in combination, hyaluronic acid and chondroitin sulfate alleviate ECM degradation in osteoarthritis by inhibiting the NF-κB pathway
by: Yiran Ma, et al.
Published: (2025-01-01) -
Biogenic nanoparticles as a promising drug delivery system
by: Rehab M. Abdel-Megeed
Published: (2025-06-01) -
Formation of hybrid carriers based on albumin and polyoxometalate for targeted drug delivery
by: M.O. Tonkushina, et al.
Published: (2024-12-01) -
N-Oxalylglycine-Conjugated Hyaluronic Acid as a Macromolecular Prodrug for Therapeutic Angiogenesis
by: Andrew H. DeMaria, et al.
Published: (2025-01-01) -
Development of a conjunctival contact–type drug delivery device for latanoprost using hyaluronic acid
by: Soomin Lee, et al.
Published: (2025-12-01)